Ruthenium(II) complexes containing 4‐methoxybenzhydrazone ligands: synthesis,characterization, DNA binding,DNA cleavage,radical scavenging and in vitro cytotoxic activity

Three ruthenium(II) hydrazone complexes of composition [RuCl(CO)(PPh₃)₂L] were synthesized from the reactions of [RuHCl(CO)(PPh₃)₃] with hydrazones derived from 4‐methoxybenzhydrazide and 4‐formylbenzoic acid (HL¹), 4‐methylbenzaldehyde (HL²) and 2‐bromobenzaldehyde (HL³). The synthesized hydrazone ligands and their metal complexes were characterized using elemental analysis and infrared, UV–visible, NMR (¹H, ¹³C and ³¹P) and mass spectral techniques. The hydrazone ligands act as bidentate ones, with O and N as the donor sites, and are predominantly found in the enol form in all the complexes studied. The molecular structures of the ligands HL¹, HL² and HL³ were determined using single‐crystal X‐ray diffraction. The interactions of the ligands and the complexes with calf thymus DNA were studied using absorption spectroscopy and cyclic voltammetry which revealed that the compounds could interact with calf thymus DNA through intercalation. The DNA cleavage activity of the complexes was evaluated using a gel electrophoresis assay which revealed that the complexes act as good DNA cleavage agents. In addition, all the complexes were subjected to antioxidant assay, which showed that they all possess significant scavenging activity against 2,2‐diphenyl‐2‐picrylhydrazyl, OH and NO radicals. The in vitro cytotoxic effect of the complexes examined on cancerous cell lines (HeLa and MCF‐7) showed that the complexes exhibit substantial anticancer activity. Copyright © 2016 John Wiley & Sons, Ltd.     

含季铵盐的芳酰腙配体的铜(Ⅱ)配合物的合成和表征:体外DNA键合和核酸酶活性

制备了2个新的含有N,N,N-三甲基丙烷-1-铵基团和N,N,N-三甲基戊烷-1-铵基团的苯乙酮-（4-羟基苯腙）配体：（E）-3-（4-（1-（2-（4-hydroxybenzoyl）hydrazono）ethyl）phenoxy）-N,N,N-trimethylpropan-1-ammonium perchlorate（H₂L¹）和（E）-3-（4-（1-（2-（4-hy-droxybenzoyl）hydrazono）ethyl）phenoxy）-N,N,N-trimethylpentane-1-ammonium perchlorate（H₂L²）。以这2个配体分别合成了2个新的铜配合物：[Cu（HL¹）₂]和[Cu（HL²）₂],研究了这些配体和配合物的DNA结合和切割活性,还研究了DNA切割的机理以及化合物浓度对DNA切割反应的影响。紫外-可见光谱结果表明,所有化合物均优先通过主沟结合模式与DNA结合,在甲基绿（主要的沟结合剂）的存在下切割DNA的活性受到抑制的结果也支持这一结论。电泳研究的结果则表明,化合物在存在或不存在氧化剂（H₂O₂）的情况下均对质粒DNA表现出显著的切割活性,活性主要取决于化合物的浓度。化合物通过水解途径裂解pBR322DNA,在存在不同自由基清除剂情况下的DNA裂解实验也支持这一结论。     

Effect of Structure and Composition of Copper and Cobalt Complexes with Schiff Base Ligands on their DNA/Protein Interaction and Cytotoxicity

Four transition metal complexes, namely Cu₂Cl₂(HL¹)₂ ( 1 ), Co(HL¹)₂ ( 2 ), Cu(HL²)₂ ( 3 ), Co(HL²)₃ ( 4 ) {H₂L¹ = 2‐{[2‐(2‐hydroxy‐ethoxy)‐ethylimino]‐methyl}‐phenol, H₂L² = 3‐{[2‐(2‐hydroxy‐ethoxy)‐ethylimino]‐methyl}‐naphthalen‐2‐ol} were synthesized and characterized by single‐crystal X‐ray diffraction, IR spectroscopy, and elemental analysis. The interactions of these copper and cobalt complexes with calf thymus DNA (CT‐DNA) were studied by absorption and emission titration spectroscopic methods. The interactions of these copper and cobalt complexes with bovine serum albumin (BSA) were also investigated using fluorescence, UV/Vis, and synchronous fluorescence spectroscopy. Further, the in vitro cytotoxic effect of the complexes are examined on human colon carcinoma cell lines (HCT‐116) and human lung carcinoma cell line (A549).     

Heteroscorpionate‐based heteroleptic copper(II) complexes: Antioxidant,molecular docking and in vitro cytotoxicity studies

Three new heteroscorpionate ligands, (2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL¹), (4‐diethylamino‐2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL²) and (5‐bromo‐2‐hydroxyphenyl)bis(imidazol‐1‐yl)methane (HL³), and their heteroleptic copper(II) complexes of the type [Cu(L^1–3)diimine]ClO₄ ( 1 – 6 ; where diimine =2,2′‐bipyridyl or 1,10‐phenanthroline) have been synthesized and characterized using spectroscopic methods. The molecular structure of ligand HL¹ was determined by single‐crystal X‐ray diffraction. UV–visible, electron paramagnetic resonance and theoretical studies suggest a distorted square pyramidal geometry around copper(II) ion. Analyses of highest occupied and lowest unoccupied molecular orbitals have been used to explain the charge transfer taking place within the complexes. The antioxidant activities of the heteroscorpionate ligands and their heteroleptic copper(II) complexes were determined using ABTS, DPPH and H₂O₂ free radical scavenging assays with respect to standard antioxidant ascorbic acid. In molecular docking studies, the complexes showed π–π, hydrogen bonding, van der Waals and electrostatic interactions with fibroblast growth factor receptor kinase. In vitro cytotoxicity activities of ligands and copper(II) complexes were examined on human breast adenocarcinoma (MCF‐7), cervical (HeLa) and lung (A549) cancer cell lines and normal human dermal fibroblast cell line using MTT assay. Complex 4 exhibited higher anticancer activity than the other complexes against all three cancer lines, being more potent than the standard drug cisplatin.     

Manganese(II) complexes of hydrazone based NNO-donor ligands and their catalytic activity in the oxidation of olefins

The reaction between tridentate NNO donor hydrazone ligands, (E)-2-cyano-N′-(phenyl(pyridin-2-yl)methylene)acetohydrazide (HL¹) and (E)-2-cyano-N′-(1-(pyridin-2-yl)ethylidene)acetohydrazide (HL²), with MnCl₂·4H₂O in methanol resulted in [Mn(HL¹)Cl₂(CH₃OH)] (1) and [Mn(HL²)Cl₂(CH₃OH)] (2). Molecular structures of the complexes were determined by single-crystal X-ray diffraction. All of the investigated compounds were further characterized by elemental analysis, FT-IR, TGA, and UV–Vis spectroscopy. These complexes were used as catalysts for olefin oxidation in the presence of tert-butylhydroperoxide (TBHP) as an oxidant. Under similar experimental conditions with equal manganese loading, the presence of [Mn(HL²)Cl₂(CH₃OH)] (2) resulted in higher conversion than [Mn(HL¹)Cl₂(CH₃OH)] (1).     

In vitro anti‐proliferative and in silico docking studies of heteroleptic copper(II) complexes of pyridazine‐based ligands and ciprofloxacin

Three heteroleptic copper(II) complexes of the type [Cu(L^1–3)(cf)(ClO₄)] ( 1 – 3 ), where cf = ciprofloxacin, have been synthesized using pyridazine‐based ligands 3‐chloro‐6‐(salicylidenehydrazinyl)pyridazine (HL¹), 3‐chloro‐6‐(4‐diethylaminosalicylidenehydrazinyl)pyridazine (HL²) and 3‐chloro‐6‐(5‐bromosalicylidenehydrazinyl)pyridazine (HL³). Electronic spectral data and magnetic moment values suggest octahedral geometry for the synthesized copper(II) complexes. Electrochemical data of the copper(II) complexes present an irreversible one‐electron reduction wave in the cathodic potential region (E_pc) between ?0.631 and ?0.670 V. Frontier molecular orbital calculations were carried out, and the obtained low‐energy gap supports the bio‐efficacy of the complexes. All the complexes were screened for their in vitro cytotoxicity activity against three human cancerous (breast adenocarcinoma (MCF‐7), hepatoma (HepG‐2) and cervical (HeLa)) and one non‐cancerous (non‐tumorigenic human dermal fibroblast (NHDF)) cell lines using MTT assay, in which complex 2 exhibited higher activity. The apoptosis induction by the complexes was analysed using the Hoechst dye staining method with MCF‐7 cell line, which indicates higher apoptotic activity of complex 2 . A molecular docking study was carried out to ascertain the binding affinity of the synthesized heteroleptic copper(II) complexes with phosphoinositide 3‐kinase gamma (PI3Kγ) receptor.     

Four‐, five‐ and six‐coordinated transition metal complexes based on naphthalimide Schiff base ligands: Synthesis,crystal structure and properties

Two bidentate Schiff base ligands (HL¹ = N‐n‐butyl‐4‐[(E)‐2‐(((2‐aminoethyl)imino)methyl)phenol]‐1,8‐naphthalimide; and HL² = N‐n‐butyl‐4‐[(E)‐2‐(((2‐aminoethyl)imino)methyl)‐6‐methoxyphenol]‐1,8‐naphthalimide) with their metal complexes [Cu(L¹)₂] ( 1 ), [Zn(L¹)₂(Py)]₂?H₂O ( 2 ) and [Ni(L²)₂(DMF)₂] ( 3 ) have been synthesized and characterized. Single‐crystal X‐ray structure analysis reveals that complex 1 has a four‐coordinated square geometry, while complex 2 is a five‐coordinated square pyramidal structure and complex 3 is a distorted six‐coordinated octahedral structure. Cyclic voltammograms of 1 indicate an irreversible Cu²⁺/Cu⁺ couple. In vitro antioxidant activity assay demonstrates that the ligands and the two complexes 1 and 3 display high scavenging activity against hydroxyl (HO^?) and superoxide (O₂^??) radicals. Moreover, the fluorescence properties of the ligands and complexes 1 – 3 were studied in the solid state. Metal‐mediated enhancement is observed in 2 , whereas metal‐mediated fluorescence quenching occurs with 1 and 3 .     

Synthesis,Structure, Magnetic and Photoluminescent Properties of Dysprosium(III) Schiff Base Single‐Molecule Magnets: Investigation of the Relaxation of the Magnetization

We report here the synthesis, structure, magnetic and photoluminescent properties of three new bifunctional Schiff‐base complexes [Dy(L₁)₂(py)₂][B(Ph)₄]?py ( 1 ), [Dy(L₁)₂Cl(DME)] ? 0.5DME ( 2 ) and [Dy(L₂)₂Cl] ? 2.5(C₇H₈) ( 3 ) (HL₁=Phenol, 2,4‐bis(1,1‐dimethylethyl)‐6‐[[(2‐methoxy‐5‐methylphenyl)imino]methyl]; HL₂=Phenol, 2,4‐bis(1,1‐dimethylethyl)‐6‐[[(2‐methoxyphenyl)imino]methyl]). The coordination environment of the Dy³⁺ ion and the direction of the anisotropic axis may be controlled by the combination of the substituent groups of the Schiff bases, the nature of the counter‐ions (Cl^? vs. BPh₄^?) and the coordinative solvent molecules. A zero‐field slow relaxation of the magnetization is evidenced for all complexes but strong differences in the relaxation dynamics are observed depending on the Dy³⁺ site geometry. In this sense, complex 1 exhibits an anisotropy barrier of 472 cm^?1_, which may be favourably compared to other related examples due to the shortening of the Dy?O bond in the axial direction. Besides, the three complexes exhibit a ligand‐based luminescence making them as bifunctional magneto‐luminescent systems.     

Synthesis,characterization, and structures of copper(I) complexes with N,N′-bis[1-(4-chlorophenyl)ethylidene]ethane-1,2-diamine and N,N′-bis[1-(4-nitrophenyl)ethylidene]ethane-1,2-diamine

Two ligands, N,N′-bis[1-(4-chlorophenyl)ethylidene]ethane-1,2-diamine (L¹ ) and N,N′-bis- [1-(4-nitrophenyl)ethylidene]ethane-1,2-diamine (L² ) and their corresponding copper(I) complexes, [Cu(L ¹)₂]ClO₄ (1) and [Cu(L ²)₂]ClO₄ (2), have been synthesized and characterized by CHN analyses, ¹H-NMR, IR, and UV–Vis spectroscopy. The crystal structures of L¹ and [Cu(L ¹)₂]ClO₄ (1) were determined from single crystal X-ray diffraction. L¹ lies across a crystallographic inversion center and the C=N is approximately coplanar with the benzene ring and adopts E configuration. The coordination polyhedron about copper(I) in 1 is best described as a distorted tetrahedron. Quasireversible redox behavior is observed for the complexes.     

Copper(II) Complexes of 3,4,5‐Trisubstituted Pyrazolates: In Situ Formation of Pyrazole Rings from Different Carbon Centers

The synthesis and characterization of two pyrazolate‐bridged dicopper(II) complexes, [Cu₂(L¹)₂(H₂O)₂](ClO₄)₂ ( 1 , HL¹=3,5‐dipyridyl‐4‐(2‐keto‐pyridyl)pyrazole) and [Cu₂(L²)₂(H₂O)₂](ClO₄)₂ ( 2 , HL²=3,5‐dipyridyl‐4‐benzoylpyrazole), are discussed. These copper(II) complexes are formed from the reactions between pyridine‐2‐aldehyde, 2‐acetylpyridine (for compound 1 ) or acetophenone (for compound 2 ), and hydrazine hydrate with copper(II) perchlorate hydrate under ambient conditions. The single‐crystal X‐ray structure of compound 1? 2 H₂O establishes the formation of a pyrazole ring from three different carbon centers through C? C bond‐forming reactions, mediated by copper(II) ions. The free pyrazoles (HL¹ and HL²) are isolated from their corresponding copper(II) complexes and are characterized by using various analytical and spectroscopic techniques. A mechanism for the pyrazole‐ring synthesis that proceeds through C? C bond‐forming reactions is proposed and supported by theoretical calculations.     

A Facile Synthesis of Oxoindenothiazine and Dioxospiro(indene‐2,4′‐thiazine) Derivatives from (Substituted ethylidene)hydrazinecarbothioamides

(E)‐2‐[2‐(1‐Substituted ethylidene)hydrazinyl]‐5‐oxo‐9b‐hydroxy‐5,9b‐dihydroindeno[1,2‐d][1,3]‐thiazine‐4‐carbonitriles and (E)‐5‐oxo‐[(E)‐(1‐substituted ethylidene)hydrazinyl]‐2,5‐dihydroindeno[1,2‐d][1,3]thiazine‐4‐carbonitriles have been obtained from the reaction of 2‐(substituted ethylidene)hydrazinecarbothioamides with 2‐(1,3‐dioxo‐2,3‐dihydro‐1H‐inden‐2‐ylidene)propanedinitrile ( 1 ) in ethyl acetate solution. However, (Z)‐6′‐amino‐1,3‐dioxo‐3′‐substituted‐2′‐[(E)‐(1‐phenylethylidene)hydrazono]‐1,2′,3,3′‐tetrahydrospiro(indene‐2,4′‐[1,3]thiazine)‐5′‐carbonitriles were observed during the reaction of N‐substituted‐2‐(1‐phenylethylidene)hydrazinecarbothioamides with ( 1 ). The structure assignment of products has been confirmed on the basis of ¹H‐, ¹³C‐NMR, and mass spectrometry, as well as theoretical calculations.     

π–π stacking motifs in dialkylbis{5‐[(E)‐2‐aryldiazen‐1‐yl]‐2‐hydroxybenzoato}tin(IV) complexes

The diorganotin(IV) complexes of 5‐[(E)‐2‐aryldiazen‐1‐yl]‐2‐hydroxybenzoic acid are of interest because of their structural diversity in the crystalline state and their interesting biological activity. The structures of dimethylbis{2‐hydroxy‐5‐[(E)‐2‐(4‐methylphenyl)diazen‐1‐yl]benzoato}tin(IV), [Sn(CH₃)₂(C₁₄H₁₁N₂O₃)₂], and di‐n‐butylbis{2‐hydroxy‐5‐[(E)‐2‐(4‐methylphenyl)diazen‐1‐yl]benzoato}tin(IV) benzene hemisolvate, [Sn(C₄H₉)₂(C₁₄H₁₁N₂O₃)₂]·0.5C₆H₆, exhibit the usual skew‐trapezoidal bipyramidal coordination geometry observed for related complexes of this class. Each structure has two independent molecules of the Sn^IV complex in the asymmetric unit. In the dimethyltin structure, intermolecular O—H…O hydrogen bonds and a very weak Sn…O interaction link the independent molecules into dimers. The planar carboxylate ligands lend themselves to π–π stacking interactions and the diversity of supramolecular structural motifs formed by these interactions has been examined in detail for these two structures and four closely related analogues. While there are some recurring basic motifs amongst the observed stacking arrangements, such as dimers and step‐like chains, variations through longitudinal slipping and inversion of the direction of the overlay add complexity. The π–π stacking motifs in the two title complexes are combinations of some of those observed in the other structures and are the most complex of the structures examined.     

p‐Toluate‐bridged dinuclear Cu(II) complexes in combination with tridentate chelating ligand: Crystal structure,density functional theory calculation,DNA/protein binding and catecholase activity

The dinuclear Cu(II) complexes [Cu₂(L¹)₂(mb)]?ClO₄ ( 1 ) and [Cu₂(L²)₂(mb)]?ClO₄ ( 2 ) (HL¹ = 2‐[(2‐diethylaminoethylimino)methyl]phenol; HL² = 2‐[1‐(2‐diethylaminoethylimino)propyl]phenol; mb = 4‐methylbenzoate) were synthesized and characterized using X‐ray crystal structure analysis and spectroscopic methods. Complexes 1 and 2 are dinuclear with distorted square pyramidal Cu (II) geometries, where Schiff base coordinates with tridentate (N,N,O) chelating mode and mb bridges two metal centres. Optimized structures and photophysical properties of ligands and complexes were calculated using density functional theory and time‐dependent density functional theory methods using B3LYP functional with 6‐31G (d,p) and LanL2MB basis sets. Interactions of the complexes with bovine serum albumin (BSA) and human serum albumin (HSA) were studied using UV–visible absorption and fluorescence spectroscopies and the calculated values of association constants (M^?1) are 1.7 × 10⁵ ( 1 –BSA), 5.7 × 10⁵ ( 2 –BSA), 1.6 × 10⁵ ( 1 –HSA) and 6.9 × 10⁵ ( 2 –HSA). Interactions of the complexes with calf thymus DNA were also investigated and the binding affinities are 1.4 × 10⁵ and 1.6 × 10⁵ M^?1 for 1 and 2 , respectively. Both complexes catalytically oxidize 3,5‐di‐tert‐butylcatechol to 3,5‐di‐tert‐butylbenzoquinone in the presence of molecular oxygen.     

Synthesis and Crystal Structures of an Unexpected Tetranuclear Zinc(II) Complex and a Benzoquinone Compound Derived from ZnII‐ and CdII‐Promoted Reactivity of Schiff Base Ligands

An unexpected polyhydroxyl‐bridged tetranuclear Zn^II complex and a benzoquinone compound derived from metal‐ion promoted reactivity of Schiff base ligands were synthesized and characterized. The reaction of zinc(II) acetate dihydrate with oxime‐type Schiff base ligand HL¹ [HL¹ = 1‐(3‐((3,5‐dibromosalicylaldehyde)amino)phenyl)ethan‐1‐one O‐benzyl oxime] in methanol, acetone, and acetonitrile resulted in the chemoselective cleavage of the C=N bond of the Schiff base HL¹, and then the further addition of acetone to two salicylaldehyde molecules derived from cleavage of the C=N bond in situ α,α double aldol reaction promoted by Zn^II ions. The newly formed ligands H₄L² coordinate to four Zn^II ions forming a defect‐dicubane core structure [Zn^II₄(H₂L²)₂(μ₃‐OCH₃)₂(μ‐OCH₃)₂(CH₃OH)₂] ( 1 ) bridged exclusively by oxygen‐based ligands. The similar ligand HL³ [HL³ = 1‐(3‐((3,5‐dichlorosalicylaldehyde)amino)phenyl)ethan‐1‐one O‐benzyl oxime)] was employed to react with Cd^II acetate dihydrate under the same reaction conditions. No aldol addition occurred but a unexpected benzoquinone compound 2,5‐bis(((3‐(1‐((benzyloxy)imino)ethyl)phenyl)imino)methyl)‐1,4‐benzoquinone ( 2 ) formed. The results provided interesting insights into one‐pot routes involving in situ reactions act as a strategy for obtaining a variety of polymeric/polynuclear complexes which are inconvenient to obtain from directly presynthesizing the ligands.     

Synthesis and Characterization of N,N‐Di‐substituted Acylthiourea Copper(II) Complexes

A series of six N,N‐di‐substituted acylthiourea ArC(O)NHC(S)NRR′ ligands (denoted as HLⁿ) [Ar = 1‐Naph: NRR′ = NPh₂, HL¹ ( 1 ); N(iPr)Ph, HL² ( 2 ). Ar = Mes: NRR′ = NPh₂, HL⁴ ( 3 ); N(iPr)Ph, HL⁵ ( 4 ); NEt₂, HL⁶ ( 5 ). Ar = Ph: NRR′ = N(iPr)Ph, HL⁸ ( 6 )] were synthesized and characterized. These ligands were deprotonated to form Cu^II complexes through metathesis or combined redox reaction with copper halides. The structures of the complexes were investigated with single‐crystal X‐ray diffraction. The reaction of the 1‐naphthalene derivative HL¹ ( 1 ) with CuBr in the presence of sodium acetate produced cis‐CuL¹₂ ( 7 ), where the deprotonated ligand is bound to the Cu^II atom in a bidentate‐(O, S) coordination mode. Similarly treatment of HL² ( 2 ) with NaOAc and CuCl resulted in the formation of the cis‐arranged product [cis‐CuL²₂ ( 8 )]. The reaction of mesityl derivative HL⁴ ( 3 ) and CuBr with and without the addition of NaOAc gave the cis‐CuL⁴₂ ( 9 ) and cis‐(HL⁴)₂CuBr ( 10 ), respectively. In contrast, reaction of HL⁵ ( 4 ) and CuI in the presence of NaOAc resulted in trans‐CuL⁵₂ ( 11 ). Alternatively trans‐CuL⁶₂ ( 12 ) was obtained by the reaction of diethyl‐substituted HL⁶ ( 5 ) with CuCl₂ in the absence of a base.     

Synthesis,characterization and biological properties of novel ON donor bidentate Schiff bases and their copper(II) complexes

Four novel ON donor Schiff bases (E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol (HL₁),(E)-3-((4-(4-biphenyloxy)phenyliminomethyl)benzene-1,2-diol (HL₂), (E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol (HL₃), (E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol (HL₄) and their copper(II) complexes bis((E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₁)₂) bis((E)-3-((4-(4-biphenyloxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₂)₂), bis((E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₃)₂), bis((E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₄)₂) have been synthesized and characterized by spectroscopic (FTIR, NMR, UV–visible) and elemental analysis. The crystal structures of HL₁, HL₂, HL_3, and HL₄ have been determined, which reveal intramolecular N-H?O (HL₁, HL₂, HL_3, and HL₄) hydrogen bonds in the solid state. Keto-amine and enol-imine tautomerism is exhibited by the Schiff bases in solid and solution states. The Schiff bases and their copper(II) complexes have been screened for their biological activities. In antimicrobial assays (antibacterial and antifungal), HL₄ showed promising results against all strains through dual inhibition property while the rest of the compounds showed activity against selective strains. On the other hand, in cytotoxic, DPPH, and inhibition of hydroxyl (OH) free radical-induced DNA damage assays, the results were found significantly correlated with each other, i.e. the ligands HL₁ and HL₂ showed moderate activity while their complexes Cu(L₁)₂ and Cu(L₂)₂ exhibited prominent increase in activity. As the results of these assays are supporting each other, it represents the strong positive correlation and antioxidant nature of investigated compounds.     

Synthesis,structure and bioactivity of Ni2+ and Cu2+ acylhydrazone complexes

Two acylhydrazone complexes, bis{6‐methyl‐N′‐[1‐(pyrazin‐2‐yl‐κN¹)ethylidene]nicotinohydrazidato‐κ²N′,O}nickel(II), [Ni(C₁₃H₁₂N₅O)₂], (I), and di‐μ‐azido‐κ⁴N¹:N¹‐bis({6‐methyl‐N′‐[1‐(pyrazin‐2‐yl‐κN¹)ethylidene]nicotinohydrazidato‐κ²N′,O}nickel(II)), [Cu₂(C₁₃H₁₂N₅O)₂(N₃)₂], (II), derived from 6‐methyl‐N′‐[1‐(pyrazin‐2‐yl)ethylidene]nicotinohydrazide (HL) and azide salts, have been synthesized. HL acts as an N,N′,O‐tridentate ligand in both complexes. Complex (I) crystallizes in the orthorhombic space group Pbcn and has a mononuclear structure, the azide co‐ligand is not involved in crystallization and the Ni²⁺ centre lies in a distorted {N₄O₂} octahedral coordination environment. Complex (II) crystallizes in the triclinic space group P and is a centrosymmetric binuclear complex with a crystallographically independent Cu²⁺ centre coordinating to three donor atoms from the deprotonated L^? ligand and to two N atoms belonging to two bridging azide anions. The two‐ and one‐dimensional supramolecular structures are constructed by hydrogen‐bonding interactions in (I) and (II), respectively. The in vitro urease inhibitory evaluation revealed that complex (II) showed a better inhibitory activity, with the IC₅₀ value being 1.32±0.4 µM. Both complexes can effectively bind to bovine serum albumin (BSA) by 1:1 binding, which was assessed via tryptophan emission–quenching measurements. The bioactivities of the two complexes towards jack bean urease were also studied by molecular docking. The effects of the metal ions and the coordination environments in the two complexes on in vitro urease inhibitory activity are preliminarily discussed.     

Tweaking the affinity of aryl‐substituted diazosalicylato‐ and pyridine ligands towards Zn (II) and its neighbors in the periodic system of the elements,Cu (II) and Cd (II), and their antimicrobial activity

A series of six new Zn (II) compounds, viz., [Zn(HL^ASA)₂(Py)₂] ( 1 ), [Zn(HL^MASA)₂(Py)₂] ( 2 ), [Zn(HL^MASA)₂(4‐MePy)₂] ( 3 ), [Zn(HL^CASA)₂(4‐MePy)₂] ( 4 ), [Zn(HL^BASA)₂(Py)₂] ( 5 ), [Zn(HL^BASA)₂(4‐MePy)₂] ( 6 ) and representative Cu (II) and Cd (II) complexes, viz., [Cu(HL^ASA)₂(Py)₂(H₂O)] ( 7 ) and [Cd(HL^BASA)₂(Py)₃] ( 8 ) [(HL^XASA)^? = para‐substituted 5‐[(E)‐2‐(aryl)‐1‐diazenyl]‐2‐hydroxybenzoate with X = H (ASA), Me (MASA), Cl (CASA) or Br (BASA); Py = pyridine; 4‐MePy = 4‐methylpyridine] have been synthesized and characterized by spectroscopic techniques and single‐crystal X‐ray diffraction analysis. The structural characterization of the compounds revealed distorted tetrahedral ( 1 – 6 ), square‐pyramidal ( 7 ) and pentagonal‐bipyramidal ( 8 ) coordination geometries around the metal atom, in which the aryl‐substituted diazosalicylate ligands are coordinated only through the oxygen atoms of carboxylate groups, either in an anisobidentate or isobidentate mode; meanwhile, the 2‐hydroxy groups of the monoanionic ligand (HL^XASA)^? are involved only in intramolecular O‐H···O hydrogen bonds with the carboxylate function. In the crystal structures of 1 – 8 , the complex molecules are assembled by π‐stacking interactions giving mostly infinite 1D strands. The intermolecular binding in the solid state structures is accomplished by diverse additional non‐covalent contacts including C‐H···O, C‐H···N, C‐H···π, C‐H···Br, O···Br, Br···π and van der Waals contacts. Although the primary and secondary ligands in the Zn (II) complex series 1 – 6 carry different substituents at the periphery (X = H, Me, Cl, Br for (HL^XASA)^? and R = H, Me for 4‐Py‐R), five of the crystal structures were isostructural. Additionally, the antimicrobial activity of the pro‐ligands H₂L^XASA and their Zn (II), Cu (II) and Cd (II) compounds were studied in a comparative manner, showing high sensitivity (IZD ≥ 20) against Bacillus subtilis.     

Copper complexes with a flexible piperazinyl arm: nuclearity driven catecholase activity and interactions with biomolecules

Three new Cu(II) complexes, [Cu(HL¹)(pyridine)(H₂O)](ClO₄)₂·2MeOH (1), [Cu₂(HL¹)₂(NO₃)₂](NO₃)₂·3H₂O (2) and [Cu(HL₂)(NO₃)₂]·MeCN (3), have been synthesized from two Schiff base ligands [HL¹ = 1-phenyl-3-((2-(piperazin-4-yl)ethyl)imino)but-1-en-1-ol and HL² = 4-((2-(piperazin-1-yl)ethyl)imino)pent-2-en-2-ol] using the chair conformer of a flexible piperazinyl moiety. Structural analysis reveals that 1 and 3 are monomeric Cu(II) complexes consisting of five- and six-coordinate Cu(II), respectively, whereas 2 is a dinuclear Cu(II) complex consisting of two different Cu(II) centers, one square planar with the other distorted octahedral. Screening tests were conducted to quantify the binding of 1–3 towards DNA and BSA as well as the DNA cleavage activity of these complexes using gel electrophoresis. Enzyme kinetic studies were also performed for the complexes mimicking catecholase-like activities. Antibacterial activities of these complexes were also examined towards Methicillin-Resistant Staphylococcus aureus bacteria. The results reflect that 2 is more active than the monomeric complexes, which is further corroborated by density functional theory study.     

Synthesis,structure, and properties of coordination compounds of copper(II) acetate with substituted 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}phenol

Salicylic, 5-chloro-5-bromo-5-nitro-, 3-methoxysalicylic, 2-hydroxy-1-naphthoic aldehydes and 2,3-, 2,4-, and 2,5-dihydroxybenzaldehyde were shown to react in ethanol with 2-(2-aminoethylamino)ethanol in the presence of copper acetate hydrate forming coordination compounds Cu(L^1-9)CH₃COO {HL^1-8, 2-([2-(2-hydroxyethylamino)ethylimino]methyl}phenol (HL¹) and respective chloro(HL²), bromo- (HL³), nitro- (HL⁴), methoxy- (HL⁸), or hydroxy-substituted (HL^5-7); HL⁹, 2-{[2-(2-hydroxyethylamine)ethylimino] methylnaphthol)}. Structure of the complex Cu(L³)CH₃COO was determined by X-ray diffraction analysis. Coordination polyhedron of its central atom is a distorted tetragonal bipyramid with (4+1+1) modes of coordinating the copper atom. The bipyramid base is formed by the atoms of phenol oxygen and of azomethine and imine nitrogen atoms of the ligand (HL³) and the oxygen atom of the acetate ion. Axial apices of the bipyramid are occupied by the alcohol oxygen atoms of the azomethine (HL³) and the second oxygen atom of the acetate ion. Other complexes are also of monomer structure. Azomethines (HL^1-9) behave as monodeprotonated tetradentate O,N,N,O ligands. The thermolysis of substances includes a stage of complete thermal decomposition (360–530°C). Synthesized complexes show selective antimicrobial activity against a series of standard strains of Staphylococcus aureus and E. coli at the concentration in the range of 75–300 μg ml⁻¹.